DK161524C - Fremgangsmaade til isolering af et praeparat af et osteogent protein samt et praeparat i stand til at fremme osteogenese fremstillet ved fremgangsmaaden - Google Patents

Fremgangsmaade til isolering af et praeparat af et osteogent protein samt et praeparat i stand til at fremme osteogenese fremstillet ved fremgangsmaaden

Info

Publication number
DK161524C
DK161524C DK002285A DK2285A DK161524C DK 161524 C DK161524 C DK 161524C DK 002285 A DK002285 A DK 002285A DK 2285 A DK2285 A DK 2285A DK 161524 C DK161524 C DK 161524C
Authority
DK
Denmark
Prior art keywords
preparation
procedure
protein
osteogent
insulating
Prior art date
Application number
DK002285A
Other languages
Danish (da)
English (en)
Other versions
DK2285D0 (da
DK161524B (da
DK2285A (da
Inventor
Arup Sen
Original Assignee
Int Genetic Eng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Genetic Eng filed Critical Int Genetic Eng
Publication of DK2285D0 publication Critical patent/DK2285D0/da
Publication of DK2285A publication Critical patent/DK2285A/da
Publication of DK161524B publication Critical patent/DK161524B/da
Application granted granted Critical
Publication of DK161524C publication Critical patent/DK161524C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Magnetic Heads (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK002285A 1984-01-04 1985-01-02 Fremgangsmaade til isolering af et praeparat af et osteogent protein samt et praeparat i stand til at fremme osteogenese fremstillet ved fremgangsmaaden DK161524C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56816784A 1984-01-04 1984-01-04
US56816784 1984-01-04

Publications (4)

Publication Number Publication Date
DK2285D0 DK2285D0 (da) 1985-01-02
DK2285A DK2285A (da) 1985-07-05
DK161524B DK161524B (da) 1991-07-15
DK161524C true DK161524C (da) 1991-12-23

Family

ID=24270176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK002285A DK161524C (da) 1984-01-04 1985-01-02 Fremgangsmaade til isolering af et praeparat af et osteogent protein samt et praeparat i stand til at fremme osteogenese fremstillet ved fremgangsmaaden

Country Status (11)

Country Link
EP (1) EP0148155B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS60226814A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE42309T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU580975B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1241641A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3569542D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK161524C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR850006B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE57966B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ210699A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA8547B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795804A (en) * 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4627982A (en) * 1984-07-16 1986-12-09 Collagen Corporation Partially purified bone-inducing factor
JPH0723322B2 (ja) * 1985-12-07 1995-03-15 克之 藤井 液状骨形成剤からなる注射液
US6432919B1 (en) 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US4877864A (en) * 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
EP0271668B1 (de) * 1986-10-22 1991-12-18 Gesellschaft für Biotechnologische Forschung mbH (GBF) Wachstumstimulierendes Material, Herstellungsverfahren und therapeutische Zusammensetzung
IL89869A0 (en) * 1988-04-06 1989-12-15 Collagen Corp Bone-inducing protein
US5670336A (en) * 1988-04-08 1997-09-23 Stryker Corporation Method for recombinant production of osteogenic protein
US4968590A (en) * 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5162114A (en) * 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
DE01201546T1 (de) * 1988-04-08 2004-07-08 Stryker Corp., Kalamazoo Osteogene Einrichtungen
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5250302A (en) * 1988-04-08 1993-10-05 Stryker Corporation Osteogenic devices
US4975526A (en) * 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5324819A (en) * 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
IL90683A0 (en) * 1988-06-27 1990-01-18 Yissum Res Dev Co Osteogenic growth factors derived from regenerating bone marrow
US5106626A (en) * 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
JPH03151877A (ja) * 1989-06-02 1991-06-28 Chiron Corp 骨カルシウム沈着因子
CA2020729A1 (en) * 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein
EP0448704B1 (en) * 1989-10-17 1998-06-17 Stryker Corporation Osteogenic devices
US5645591A (en) * 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US6090776A (en) * 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
US6949505B1 (en) 1991-03-11 2005-09-27 Curis, Inc. Morphogen-induced dendritic growth
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US6399569B1 (en) 1991-03-11 2002-06-04 Curis, Inc. Morphogen treatments for limiting proliferation of epithelial cells
US5656593A (en) * 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
CA2363965C (en) 1991-03-11 2010-05-18 Curis, Inc. Protein-induced morphogenesis
US5652337A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US5849686A (en) * 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US6495513B1 (en) 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5652118A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US5972884A (en) * 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US6022853A (en) * 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
EP0612348B1 (en) 1991-11-04 2003-04-23 Genetics Institute, LLC Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
ATE258984T1 (de) 1993-05-12 2004-02-15 Inst Genetics Llc Bmp-11 zusammensetzungen
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
DE69434651T2 (de) 1993-12-07 2007-03-08 Genetics Institute, Inc., Cambridge Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US5928940A (en) * 1996-09-24 1999-07-27 Creative Biomolecules, Inc. Morphogen-responsive signal transducer and methods of use thereof
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
EP2286847A1 (en) 1999-10-15 2011-02-23 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
DE60332848D1 (de) 2002-06-20 2010-07-15 Altis Biolog Pty Ltd Osteoinduktive biomaterialien
AU2004272072B2 (en) 2003-09-12 2010-07-08 Etex Corporation Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
WO2005065396A2 (en) 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US8734525B2 (en) 2003-12-31 2014-05-27 Warsaw Orthopedic, Inc. Osteoinductive demineralized cancellous bone
EP1771470B1 (en) 2004-07-23 2013-06-26 Acceleron Pharma Inc. Actrii receptor polypeptides, methods and compositions
EP1942960B1 (en) 2005-11-01 2012-08-29 Warsaw Orthopedic, Inc. Methods for producing bone matrix composition
TW201940502A (zh) 2007-02-02 2019-10-16 美商艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
WO2008157495A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Bone matrix compositions and methods
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
CA3062443C (en) 2007-06-15 2022-03-15 Warsaw Orthopedic, Inc. Method of treating tissue
WO2009009688A1 (en) 2007-07-10 2009-01-15 Osteotech, Inc. Delivery system
AU2008311785A1 (en) 2007-10-19 2009-04-23 Warsaw Orthopedic, Inc. Demineralized bone matrix compositions and methods
WO2010093959A2 (en) 2009-02-12 2010-08-19 Osteotech, Inc. Delivery systems, tools, and methods of use
EP2501400B1 (en) 2009-11-17 2017-11-01 Acceleron Pharma, Inc. Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
CN110036025B (zh) 2016-10-05 2024-03-22 阿塞勒隆制药公司 变体ActRIIB蛋白及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4608199A (en) * 1984-03-20 1986-08-26 Arnold Caplan Bone protein purification process

Also Published As

Publication number Publication date
ZA8547B (en) 1986-09-24
AU3722184A (en) 1985-07-11
EP0148155A3 (en) 1986-08-13
DK2285D0 (da) 1985-01-02
AU580975B2 (en) 1989-02-09
ATE42309T1 (de) 1989-05-15
IE850010L (en) 1985-07-04
GR850006B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-05-03
EP0148155B1 (en) 1989-04-19
JPS60226814A (ja) 1985-11-12
CA1241641A (en) 1988-09-06
EP0148155A2 (en) 1985-07-10
NZ210699A (en) 1989-06-28
IE57966B1 (en) 1993-06-02
DK161524B (da) 1991-07-15
DK2285A (da) 1985-07-05
DE3569542D1 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
DK161524C (da) Fremgangsmaade til isolering af et praeparat af et osteogent protein samt et praeparat i stand til at fremme osteogenese fremstillet ved fremgangsmaaden
DK295287D0 (da) Fremgangsmaade til fremstilling af ravsyre ved anaerob fermentering
PT87492A (pt) Process for the preparation of benzo ]b" pyrrans and pyranopyridines and pharmaceutical compositions containing them
DK158229C (da) Analogifremgangsmaade til fremstilling af 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller alkanoyl-derivater deraf eller farmaceutisk acceptable syreadditionssalte deraf og n,n'-dioxidet deraf til anvendelse som udgangsmateriale ved fremgangsmaaden
HUT51279A (en) Process for producing 2-phosphate-esters of ascorbinic acid and pharmaceutical compositions containing them as active components
IT1184125B (it) Procedimento per la preparazione di composti al vanadio da residui contenenti vanadio
NO170540C (no) En analogifremgangsmaate for fremstilling av 1-hydroksy-2-pyridoner
DK423189A (da) Fremgangsmaade til fremstilling af 1,3-propandiol ved fermentering
DK246985D0 (da) Triterpenylestere af organiske syrer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne triterpenylestere
PT84088B (pt) Processo de preparacao de novos derivados do acido 4-amino-9h-pirido 2,3-b indol-carboxilico-(3) e de composicoes farmaceuticas contendo-os
NO875239D0 (no) Fremgangsmaate ved spalting av 1,4-dihydropyridinderivater i optisk aktive isomerer.
DK328788D0 (da) Fremgangsmaade til fremstilling af et aromatiseringsmiddel
ES8705434A1 (es) Procedimiento para la preparacion de derivados de acido 4-(isoxazolil)-tiazol-2-oxamico
DK412187D0 (da) Fremgangsmaade til fremstilling af et n-acetylneuraminsyreholdigt trisaccharid
FR2599738B1 (fr) Nouveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique, leur procede de preparation, leur application comme medcaments et les compositions les renfermant
NO852741L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater
DK323888D0 (da) Fremgangsmaade til hydrogenering af dobbeltbindinger
FR2574296B1 (fr) Procede de stabilisation par fermentation speciale d'extraits de plantes fraichement prepares
DK206287D0 (da) Fremgangsmaade til mikrobiel fremstilling af l-aminosyrer ved transminering
AU8282987A (en) Composition for defoliation of plants i
GB8804761D0 (en) Treatment of alcohol & alcoholic compositions
DK372289D0 (da) Metode til praeparering af podestofsektioner til plantevaevskultur
IT8629082V0 (it) Cinematismo particolarmente idoneo per macchine zollatrici di piante da trapiantare
NO173062C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzo(5,6)cykloheptapyridiner
IT8520515A0 (it) Composizioni di farmaci eprocedimento per la loro preparazione.

Legal Events

Date Code Title Description
PBP Patent lapsed